LeAnn B. Norris

1.2k total citations
38 papers, 790 citations indexed

About

LeAnn B. Norris is a scholar working on Oncology, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, LeAnn B. Norris has authored 38 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Hematology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in LeAnn B. Norris's work include Polyomavirus and related diseases (8 papers), Erythropoietin and Anemia Treatment (7 papers) and Pharmaceutical studies and practices (5 papers). LeAnn B. Norris is often cited by papers focused on Polyomavirus and related diseases (8 papers), Erythropoietin and Anemia Treatment (7 papers) and Pharmaceutical studies and practices (5 papers). LeAnn B. Norris collaborates with scholars based in United States, United Kingdom and Singapore. LeAnn B. Norris's co-authors include Charles L. Bennett, P. Brandon Bookstaver, Jamés O. Armitage, Benjamin Djulbegović, Oliver Sartor, Dennis W. Raisch, Bryan L. Love, Sudha Xirasagar, Henrik S. Thomsen and April D. Miller and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

LeAnn B. Norris

33 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
LeAnn B. Norris United States 15 231 122 90 84 82 38 790
Catherine Rioufol France 17 246 1.1× 50 0.4× 90 1.0× 69 0.8× 32 0.4× 89 969
Andrea Baran United States 17 174 0.8× 337 2.8× 90 1.0× 133 1.6× 172 2.1× 81 1.1k
Virginie Nerich France 20 334 1.4× 221 1.8× 93 1.0× 125 1.5× 41 0.5× 83 1.2k
Rajiv Mallick United States 19 245 1.1× 167 1.4× 222 2.5× 44 0.5× 71 0.9× 70 1.3k
M. A. Mangues Spain 20 136 0.6× 92 0.8× 30 0.3× 42 0.5× 139 1.7× 49 1.0k
Étienne Lemarié France 16 355 1.5× 131 1.1× 53 0.6× 92 1.1× 55 0.7× 31 1.5k
Paula M. Termuhlen United States 19 311 1.3× 68 0.6× 247 2.7× 93 1.1× 38 0.5× 50 1.3k
Seung Hun Jang South Korea 22 367 1.6× 202 1.7× 55 0.6× 47 0.6× 78 1.0× 140 1.6k
Peter Schellongowski Austria 20 300 1.3× 310 2.5× 97 1.1× 71 0.8× 97 1.2× 66 1.5k
Gin Gin Gan Malaysia 15 185 0.8× 72 0.6× 87 1.0× 79 0.9× 49 0.6× 81 823

Countries citing papers authored by LeAnn B. Norris

Since Specialization
Citations

This map shows the geographic impact of LeAnn B. Norris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LeAnn B. Norris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LeAnn B. Norris more than expected).

Fields of papers citing papers by LeAnn B. Norris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LeAnn B. Norris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LeAnn B. Norris. The network helps show where LeAnn B. Norris may publish in the future.

Co-authorship network of co-authors of LeAnn B. Norris

This figure shows the co-authorship network connecting the top 25 collaborators of LeAnn B. Norris. A scholar is included among the top collaborators of LeAnn B. Norris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LeAnn B. Norris. LeAnn B. Norris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Norris, LeAnn B., et al.. (2021). Challenges of BK Viremia in Heart Transplant Recipient with Multiple Comorbidities. The Journal of Heart and Lung Transplantation. 40(4). S483–S484.
3.
Knopf, Kevin, et al.. (2018). Cost-Effective Use of White Blood Cell Growth Factors in the Veterans Administration. Blood. 132(Supplement 1). 4761–4761.
4.
5.
Norris, LeAnn B., et al.. (2017). Systematic review of antimicrobial lock therapy for prevention of central-line-associated bloodstream infections in adult and pediatric cancer patients. International Journal of Antimicrobial Agents. 50(3). 308–317. 50 indexed citations
6.
Norris, LeAnn B., Peter Georgantopoulos, Gowtham Rao, Oliver Sartor, & Charles L. Bennett. (2015). Rituximab is associated with increased risk of Progressive Multifocal Leukoencephalopathy developing among non-HIV-infected Veterans with Chronic Lymphocytic Leukemia.. Journal of Clinical Oncology. 33(15_suppl). e18033–e18033. 3 indexed citations
7.
Love, Bryan L., et al.. (2015). Screening for viral hepatitis prior to rituximab chemotherapy. Annals of Hematology. 95(1). 27–33. 9 indexed citations
8.
9.
Jarkowski, Anthony, LeAnn B. Norris, & Van Anh Trinh. (2014). Controversies in the Management of Advanced Melanoma. Annals of Pharmacotherapy. 48(11). 1456–1468. 10 indexed citations
10.
Carson, Kenneth R., Scott D. Newsome, Ellen J. Kim, et al.. (2014). Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer. 120(16). 2464–2471. 91 indexed citations
11.
Chen, Brian, et al.. (2013). Emerging drugs for treatment of anemia of chronic kidney disease. Expert Opinion on Emerging Drugs. 18(4). 421–429. 5 indexed citations
12.
Bennett, Charles L., Benjamin Djulbegović, LeAnn B. Norris, & Jamés O. Armitage. (2013). Colony-Stimulating Factors for Febrile Neutropenia during Cancer Therapy. New England Journal of Medicine. 368(12). 1131–1139. 122 indexed citations
13.
Bookstaver, P. Brandon, et al.. (2012). Assessing Pharmacy Residents' Knowledge of Biostatistics and Research Study Design. Annals of Pharmacotherapy. 46(7-8). 991–999. 47 indexed citations
14.
Stafkey-Mailey, Dana, et al.. (2012). Changes in the use of eythropoetin-stimulating agents (ESAs) in cancer patients: Before and after FDA safety advisories.. Journal of Clinical Oncology. 30(15_suppl). 9143–9143. 2 indexed citations
15.
16.
Bennett, Charles L., Karen M. Starko, Henrik S. Thomsen, et al.. (2012). Linking Drugs to Obscure Illnesses: Lessons from Pure Red Cell Aplasia, Nephrogenic Systemic Fibrosis, and Reye’s Syndrome. A Report From the Southern Network on Adverse Reactions (SONAR). Journal of General Internal Medicine. 27(12). 1697–1703. 16 indexed citations
17.
Bennett, Charles L., Zahida Qureshi, Oliver Sartor, et al.. (2012). Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease. Clinical Kidney Journal. 5(1). 82–88. 65 indexed citations
18.
Chen, Brian, LeAnn B. Norris, Sudha Xirasagar, et al.. (2012). A Tale of Two Citizens: A State Attorney General and a Hematologist Facilitate Translation of Research Into US Food and Drug Administration Actions—A SONAR Report. Journal of Oncology Practice. 8(6). e158–e167. 3 indexed citations
19.
Raisch, Dennis W., Vishvas Garg, Zaina P. Qureshi, et al.. (2011). Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication. Expert Opinion on Drug Safety. 10(4). 521–528. 21 indexed citations
20.
Norris, LeAnn B., et al.. (2010). Intravenous ibuprofen: the first injectable product for the treatment of pain and fever. Journal of Pain Research. 3. 67–67. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Rioufol Breakdown of academic impact, for papers by Andrea Baran Breakdown of academic impact, for papers by Virginie Nerich Breakdown of academic impact, for papers by Rajiv Mallick Breakdown of academic impact, for papers by M. A. Mangues Breakdown of academic impact, for papers by Étienne Lemarié Breakdown of academic impact, for papers by Paula M. Termuhlen Breakdown of academic impact, for papers by Seung Hun Jang Breakdown of academic impact, for papers by Peter Schellongowski Breakdown of academic impact, for papers by Gin Gin Gan
Rankless by CCL
2026